Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564662 · ClinicalTrials.gov registry record
Rapid-Response EEG in Children With Suspected Status Epilepticus
A clinical trial of Status Epilepticus and Coma, sponsored by Children's Hospital at Montefiore.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06564662: Recruiting study of Status Epilepticus and Coma, sponsored by Children's Hospital at Montefiore.
NCT06564662 is a study of Status Epilepticus and Coma that is actively recruiting participants, run by Children's Hospital at Montefiore. The registered enrollment target is 60 participants, below the 2,827-participant average among 10 other Status Epilepticus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564662, a study of Status Epilepticus and Coma, is actively recruiting participants, sponsored by Children's Hospital at Montefiore.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Seizures are common in children (\~350 per 100,000 patients per year) and require immediate medical attention. If the seizure is prolonged (\> 5 minutes) it is called status epilepticus and delayed treatment leads to higher risk in drug resistance and brain injury. The current standard of care for children admitted to the ICU with established or suspected status epilepticus is to start a conventional continuous EEG study that helps diagnosing seizures by typical electro graphic patterns. It takes on average 4 hours to start and another two hours to obtain a reading by epileptologists. This is far beyond the time window of starting an EEG study (60 minutes) as recommended by the neurocritical care society. In adult ICUs, point of care "Rapid Response EEG" are becoming a new standard of care and our ICU adopted this practice in 2020. It can be easily placed by the ICU staff rather than a specifically trained EEG technician but has a lower resolution due to fewer leads (10 vs. 20). The purpose of this study is to determine wether and by how much time RR-EEG yields faster preliminary EEG reports that the previously available conventional EEG (cEEG) and wether the detection of electro graphic seizures is comparable. This is a retrospective cohort study following patients who are admitted to the PICU and are placed on either cEEG or RR-EEG for status epilepticus.
Primary Outcome
EMR order placement as a surrogate for decision making to obtain an EEG. Report time of EEG was considered the time relevant information was available to the ICU team.
Conditions Studied
Interventions
- DEVICE Rapid Response EEG
Study Locations (1)
New York
- Children's Hospital at Montefiore - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2026-12-08 |
What NCT06564662 shows while recruiting
NCT06564662 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,827-participant average among 10 other Status Epilepticus trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Status Epilepticus appearing as the primary indexed condition, and to 1 intervention - of which Rapid Response EEG is the first listed.
NCT06564662 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06564662 about?
NCT06564662 is a clinical study titled "Rapid-Response EEG in Children With Suspected Status Epilepticus". Seizures are common in children (\~350 per 100,000 patients per year) and require immediate medical attention. If the seizure is prolonged (\> 5 minutes) it is called status epilepticus and delayed treatment leads to higher risk in drug resistance and brain injury. The current standard of care for c...
What is the current status of trial NCT06564662?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2021-12-09. Estimated completion is 2026-12-08.
What conditions does trial NCT06564662 study?
This clinical trial studies the following conditions: Status Epilepticus, Coma.
What interventions are being tested in trial NCT06564662?
The interventions under investigation include: Rapid Response EEG (DEVICE).
Who is sponsoring clinical trial NCT06564662?
This trial is sponsored by Children's Hospital at Montefiore, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564662 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Epilepticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06564662's enrollment target sits among peer trials
60 8th of 10 higher than 3 of 10 other Status Epilepticus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Status Epilepticus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Improving Status Epilepticus Treatment Times
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
RECRUITING
-
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
RECRUITING · Phase 3
-
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI